Onconetix, Inc. — Director's Dealing 2023

Jan 30, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2023-01-26

Reporting Person: Ramdeen Timothy R. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-26	Stock Option	$1.29	A	2386	Acquired	2033-02-12	Common Stock (2386)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Mr. Ramdeen on January 26, 2023. 597 of the Options will vest and become exercisable on each of February 13, 2023, March 13, 2023 and April 13, 2023. The remaining 595 Options will vest on May 13, 2023.